Purpose
Methods
Results
Conclusion
Level of Evidence
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ArthroscopyReferences
- Obesity: Risk factor and predictor of osteoarthritis.Lijec Vjesn. 2009; 131: 22-26
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.Arthritis Rheum. 2008; 58: 26-35
- Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: A randomized controlled study.Am J Sports Med. 2016; 44: 664-671
- Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis.Med Ultrason. 2016; 18: 463-468
- Intra-articular hyaluronic acid injections for hip osteoarthritis.J Biol Regul Homeost Agents. 2018; 32: 1303-1309
- The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: A systematic review.BMC Musculoskelet Disord. 2015; 26: 321
- Recent advances in hyaluronic acid based therapy for osteoarthritis.Clin Transl Med. 2018; 7: 6
- Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: A randomised, multicentre, double-blind, placebo controlled trial.Ann Rheum Dis. 2010; 69: 113-119
- Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.Am J Sports Med. 2021; 49: 249-260
- Platelet-rich plasma for the management of hip and knee osteoarthritis.Curr Rheumatol Rep. 2017; 19: 24
- Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: A meta-analysis of randomized controlled trials.Arthroscopy. 2017; 33: 659-670
- Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach.Knee Surg Sports Traumatol Arthrosc. 2012; 20: 2082-2091
- Platelet-rich plasma application in chondrogenesis.Adv Biomed Res. 2014; 3: 138
- The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis.Am J Sports Med. 2014; 42: 35-41
- Cochrane handbook for systematic reviews of interventions version 5.1.0.The Cochrane Collaboration, London2011
- Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.J Rheumatol. 1988; 15: 1833-1840
- Traumatic arthritis of the hip after dislocation and acetabular fractures: Treatment by mold arthroplasty. An end-result study using a new method of result evaluation.J Bone Joint Surg Am. 1969; 51: 737-755
- Treatment of early hip osteoarthritis: ultrasound-guided platelet rich plasma versus hyaluronic acid injections in a randomized clinical trial.Joints. 2017; 5: 152-155
- Comparing intra-articular injections of leukocyte-poor platelet-rich plasma versus low molecular weight hyaluronic acid for the treatment of symptomatic osteoarthritis of the hip: A double-blind, randomized pilot study.Orthop J Sports Med. 2021; 9 (2325967120969210)
- Randomized, double-blind, controlled trial, phase III, to evaluate the use of platelet-rich plasma versus hyaluronic acid in hip coxarthrosis.Rev Esp Cir Ortop Traumatol. 2020; 64: 134-142
- Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis.Orthopedics. 2013; 36: e1501-e1508
- Studies of surgical outcome after patellar tendinopathy: Clinical significance of methodological deficiencies and guidelines for future studies. Victorian Institute of Sport Tendon Study Group.Scand J Med Sci Sports. 2000; 10: 2-11
- Radiological assessment of osteo-arthrosis.Ann Rheum Dis. 1957; 16: 494-502
- The global burden of hip and knee osteoarthritis: Estimates from the global burden of disease 2010 study.Ann Rheum Dis. 2014; 73: 1323-1330
Article Info
Publication History
Footnotes
The authors report the following potential conflicts of interest or sources of funding: O.M-D. reports royalties, Stryker; stock, MITA. J.L.D. reports paid consultant, BD , Biomet , Breg, CONMED Linvatec, DePuy, DJ Orthopaedics, Genzyme , Harvest Technologies, Joint Restoration Foundation , KCRN Research, Ossur, Regeneration Technologies, RNL Bio, Sideline Sports Docs, Zimmer . R.M.F. reports board membership, AOSSM , ISAKOS , Orthopedics Today, AAOS , American Orthopaedic Society for Sports Medicine , American Shoulder and Elbow Surgeons , Arthroscopy Association of North America , International Cartilage Restoration Society, Journal of Shoulder and Elbow Surgery; paid consultant, Allosource, Arthrex , JRF , Ossur; other, Ossur, JRF , Arthrex , Smith & Nephew. Full ICMJE author disclosure forms are available for this article online, as supplementary material.